Amgen News

Amgen | DEFA14A: Others

May 4 04:11

Amgen | 8-K: AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 3 04:08

Amgen | DEFA14A: Others

Apr 27 04:13

Amgen | DEFA14A: Others

Apr 18 04:10

Amgen | DEF 14A: Definitive information statements

Apr 18 04:06

Amgen | 8-K: AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

Feb 7 05:24

Amgen | 8-K: Amgen Announces Executive Appointments to Accelerate Innovation

Dec 14, 2023 22:16

Amgen | 8-K: Amgen Reports Third Quarter Financial Results

Oct 31, 2023 19:15

Amgen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Oct 7, 2023 04:35

Amgen | 8-K: Amgen Completes Acquisition of Horizon Therapeutics Plc

Oct 7, 2023 04:01

Amgen | 8-K: On October 5, 2023, the High Court of Ireland sanctioned the acquire Scheme

Oct 5, 2023 19:43

Amgen | 8-K: Amgen Inc.、Pillartree Limited entered into certain Transaction Agreement with Horizon Therapeutics plc

Sep 12, 2023 19:30

Amgen | 8-K: The Irish High Court set a court hearing for October 5, 2023 to consider Horizon’s application for sanction of the proposed scheme of arrangement to effect the Acquisition under Irish law.

Sep 5, 2023 21:12

Amgen | 8-K: AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

Sep 1, 2023 21:25

Amgen | 8-K: The Board of Directors of Amgen Inc. appointed Matthew C. Busch as Vice President, Finance and Chief Accounting Officer

Aug 4, 2023 05:48

Amgen | 8-K: Amgen REPORTS SECOND QUARTER FINANCIAL RESULTS

Aug 4, 2023 04:12

Amgen | 8-K: Amgen, Horizon Therapeutics Plc and Pillartree Limited, A Wholly Owned Subsidiary of Amgen Entered into a Transaction Agreement

Jun 5, 2023 20:00

Amgen | 8-K: Poll Results of Amgen Meeting

May 23, 2023 05:23

Amgen | 8-K: Entered into a Transaction Agreement

May 18, 2023 20:29

Amgen | 8-K: Amgen Proposed Acquisition of Horizon Therapeutics

May 17, 2023 05:28